Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lou

Showing results (61-70 of 184) with videos related to

Pageof 19
Sort By:
JAMA Oncology|June 2, 2019
Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients With Ovarian CancerEmil Lou, Rachel I Vogel, Spencer Hoostal, et al.
Cancer Biomarkers : Section a of Disease Markers|June 18, 2014
Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancerEmil Lou, Melissa Johnson, Camelia Sima, et al.
Communicative & Integrative Biology|October 13, 2012
Tunneling Nanotubes: A new paradigm for studying intercellular communication and therapeutics in cancerEmil Lou, Sho Fujisawa, Afsar Barlas, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome PredictionEmil Lou, Valentino Clemente, Marcel Grube, et al.
JAMA Network Open|February 27, 2024
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian CancerEmil Lou, Valentino Clemente, Marcel Grube, et al.
JNCI Cancer Spectrum|January 6, 2021
Sources of Medical Information for Oncology Physicians During the COVID-19 Pandemic: Results From a National Cross-Sectional SurveyHelen M Parsons, Rachel I Vogel, Anne H Blaes, et al.
Cancer Research Communications|May 8, 2024
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric CancerNaryan Rustgi, Sharon Wu, Timothy Samec, et al.
JMIR Cancer|March 24, 2022
Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic AnalysisUdhayvir Singh Grewal, Arjun Gupta, Jamie Doggett, et al.
Annals of Surgery|August 8, 2012
Vaccinia virus GLV-1h153 is effective in treating and preventing metastatic triple-negative breast cancerSepideh Gholami, Chun-Hao Chen, Emil Lou, et al.
JCO Oncology Practice|May 1, 2020
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient RiskEmil Lou, Shaalan Beg, Emily Bergsland, et al.
Pageof 19

Showing results (61-70 of 184) with videos related to

Sort By:
Pageof 19
JAMA Oncology|June 2, 2019
Tumor-Stroma Proportion as a Predictive Biomarker of Resistance to Platinum-Based Chemotherapy in Patients With Ovarian CancerEmil Lou, Rachel I Vogel, Spencer Hoostal, et al.
Cancer Biomarkers : Section a of Disease Markers|June 18, 2014
Serum biomarkers for assessing histology and outcomes in patients with metastatic lung cancerEmil Lou, Melissa Johnson, Camelia Sima, et al.
Communicative & Integrative Biology|October 13, 2012
Tunneling Nanotubes: A new paradigm for studying intercellular communication and therapeutics in cancerEmil Lou, Sho Fujisawa, Afsar Barlas, et al.
Biorxiv : the Preprint Server for Biology|July 10, 2023
Clinical Significance of the Stromatic Component in Ovarian Cancer: Quantity Over Quality in Outcome PredictionEmil Lou, Valentino Clemente, Marcel Grube, et al.
JAMA Network Open|February 27, 2024
Tumor-Stroma Proportion to Predict Chemoresistance in Patients With Ovarian CancerEmil Lou, Valentino Clemente, Marcel Grube, et al.
JNCI Cancer Spectrum|January 6, 2021
Sources of Medical Information for Oncology Physicians During the COVID-19 Pandemic: Results From a National Cross-Sectional SurveyHelen M Parsons, Rachel I Vogel, Anne H Blaes, et al.
Cancer Research Communications|May 8, 2024
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric CancerNaryan Rustgi, Sharon Wu, Timothy Samec, et al.
JMIR Cancer|March 24, 2022
Twitter Conversations About Pancreatic Cancer by Health Care Providers and the General Public: Thematic AnalysisUdhayvir Singh Grewal, Arjun Gupta, Jamie Doggett, et al.
Annals of Surgery|August 8, 2012
Vaccinia virus GLV-1h153 is effective in treating and preventing metastatic triple-negative breast cancerSepideh Gholami, Chun-Hao Chen, Emil Lou, et al.
JCO Oncology Practice|May 1, 2020
Modifying Practices in GI Oncology in the Face of COVID-19: Recommendations From Expert Oncologists on Minimizing Patient RiskEmil Lou, Shaalan Beg, Emily Bergsland, et al.
Pageof 19